Learn About Familial Porencephaly

What is the definition of Familial Porencephaly?

Familial porencephaly is part of a group of conditions called the COL4A1-related disorders. The conditions in this group have a range of signs and symptoms that involve fragile blood vessels. In familial porencephaly, fluid-filled cysts develop in the brain (porencephaly) during fetal development or soon after birth. These cysts typically occur in only one side of the brain and vary in size. The cysts are thought to be the result of bleeding within the brain (hemorrhagic stroke). People with this condition also have leukoencephalopathy, which is a change in a type of brain tissue called white matter that can be seen with magnetic resonance imaging (MRI).

What are the causes of Familial Porencephaly?

Mutations in the COL4A1 gene cause familial porencephaly. The COL4A1 gene provides instructions for making one component of a protein called type IV collagen. Type IV collagen molecules attach to each other to form complex protein networks. These protein networks are the main components of basement membranes, which are thin sheet-like structures that separate and support cells in many tissues. Type IV collagen networks play an important role in the basement membranes in virtually all tissues throughout the body, particularly the basement membranes surrounding the body's blood vessels (vasculature).

How prevalent is Familial Porencephaly?

Familial porencephaly is a rare condition, although the exact prevalence is unknown. At least eight affected families have been described in the scientific literature.

Is Familial Porencephaly an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Who are the top Familial Porencephaly Local Doctors?
Elite in Familial Porencephaly
Elite in Familial Porencephaly
Paris, FR 

Elisabeth Lasserve-Tournier practices in Paris, France. Ms. Lasserve-Tournier is rated as an Elite expert by MediFind in the treatment of Familial Porencephaly. Her top areas of expertise are Porencephaly, Familial Porencephaly, Moyamoya Disease, and Cerebral Cavernous Malformation.

Distinguished in Familial Porencephaly
Distinguished in Familial Porencephaly

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
Languages Spoken:
English
Accepting New Patients

Vikram Prabhu is a Neurosurgery provider in Maywood, Illinois. Dr. Prabhu is rated as a Distinguished provider by MediFind in the treatment of Familial Porencephaly. His top areas of expertise are Meningioma, Familial Porencephaly, Hydrocephalus, Awake Craniotomy, and Osteotomy. Dr. Prabhu is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Anthony L. Asher
Advanced in Familial Porencephaly
Advanced in Familial Porencephaly

Carolinas Medical Center

1000 Blythe Blvd., 
Charlotte, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Anthony Asher is a Neurosurgery provider in Charlotte, North Carolina. Dr. Asher is rated as an Advanced provider by MediFind in the treatment of Familial Porencephaly. His top areas of expertise are Spondylolisthesis, Cervical Myelopathy, Brain Tumor, Laminectomy, and Spinal Fusion. Dr. Asher is currently accepting new patients.

What are the latest Familial Porencephaly Clinical Trials?
Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage (IVH, ICH)

Summary: Intraventricular hemorrhage (IVH) is the most commonly recognized cerebral lesion on ultrasound in extremely preterm infants. Papile classification is commonly used to grade the severity of IVH. Grade III-IV IVH and other lesions noted on ultrasound including periventricular leukomalacia (pvl) porencephaly, and ventriculomegaly are well Documented to be associated with adverse neurodevelopmental o...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: September 01, 2011
Published By: National Institutes of Health